Celularity Inc CELU
$0.64
▼ -6.57%
($-0.04)
⬇️ Below Yest. Low
🎈 Low Float
Open
$0.71
Prev Close
$0.68
Day Range
$0.60 – $0.72
52W Range
$0.56 – $4.31
Market Cap
$18.39M
Beta
0.59
EPS (TTM)
$-3.59
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2019-05-23 |
| Shares Out. | 28,950,000 |
| Website | celularity.com/ ↗ |
| Phone | 18009279800 |
| Employees | 115 |
| Revenue | $4.1M |
| Gross Profit | -$3.3M |
| Net Income | -$24.4M |
| Total Assets | $107.3M |
| Total Liabilities | $145.4M |
| Equity | -$38.1M |
About Celularity Inc
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
Celularity Inc is a publicly traded company under the ticker symbol CELU on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2026-07-01)